Although we did not attempt quantification for overall merged staining for CXCR2/HLA-DR, the findings from AD cortical and hippocampal tissue implicated microglial CXCR2 as a putative inflammatory mediator in the progression of AD pathology. Here, CXCR2 is linked to Alzheimer disease.